Description

Pase 2 mg is a benzodiazepine prescribed for the management of panic disorder and complex forms of epilepsy. It is particularly useful in controlling seizures that are difficult to manage with other treatments. Ongoing use is carefully monitored by doctors due to the risk of dependence.

How It Works

Pase enhances inhibitory signalling in the brain by acting on gamma-aminobutyric acid (GABA) receptors. This mechanism suppresses panic responses and abnormal neuronal firing. The result is a calming, anticonvulsant effect that helps stabilise brain activity.

Dosage

Dosage varies depending on the medical condition being treated, patient tolerance, and clinical response. The medication is typically taken in divided doses throughout the day.

When discontinuing treatment, gradual dose reduction is essential to avoid withdrawal symptoms.

Side Effects

Commonly reported side effects include:

• Sedation or drowsiness
• Slowed thinking or reduced concentration
• Balance and coordination problems, increasing fall risk

Long-term use may lead to physical dependence, especially with higher doses or prolonged treatment.

Pregnancy & Breastfeeding

Pase is not routinely recommended during pregnancy, as exposure may cause complications or withdrawal symptoms in newborns.

Breastfeeding is generally discouraged during use, as benzodiazepines may pass into breast milk and affect infants.

Storage

Store Pase in a cool, dry place away from direct heat and moisture. Avoid humid environments such as bathrooms. Keep the medication securely stored and out of reach of children and pets.

UK Regulation

In the United Kingdom, Pase is available only with a valid prescription. It is classified as a Schedule 4 benzodiazepine. Misuse or possession without a prescription may result in legal penalties.